Cargando…

Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States

Detalles Bibliográficos
Autores principales:	Dong, Betty J, Lopez, Maria I, Grant, Robert M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892568/ https://www.ncbi.nlm.nih.gov/pubmed/31824977 http://dx.doi.org/10.1093/ofid/ofz497

Ejemplares similares

1294. Acceptability and Feasibility of a Pharmacist-led Pre-exposure Prophylaxis Program in the Midwestern United States
por: Bares, Sara, et al.
Publicado: (2018)

Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States
por: Havens, Joshua P, et al.
Publicado: (2019)

Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: MacDonald, Calum B., et al.
Publicado: (2023)

Community pharmacists’ acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
por: Booker, Connor, et al.
Publicado: (2023)

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya
por: Ngure, Kenneth, et al.
Publicado: (2017)

Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California
por: Hunter, Lauren A, et al.
Publicado: (2023)

The Effect of Pharmacist-Led Intervention on Surgical Antibacterial Prophylaxis (SAP) at an Orthopedic Unit
por: Fésüs, Adina, et al.
Publicado: (2021)

Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV
por: Broekhuis, Jordan M., et al.
Publicado: (2018)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Enhancing domestic violence advocates’ ability to discuss HIV pre-exposure prophylaxis (PrEP): Feasibility and acceptability of an educational intervention
por: Willie, Tiara C, et al.
Publicado: (2022)

A Retrospective Comparison of HIV Pre-exposure Prophylaxis (PrEP) Outcomes Between a Pharmacist-led Telehealth Clinic and In-person Clinic in a Veteran Population
por: Greenwell, Kellen, et al.
Publicado: (2023)

Pre-exposure prophylaxis in Southern Africa: feasible or not?
por: Venter, Willem Daniel François, et al.
Publicado: (2015)

Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic
por: Jayakumaran, Jenani Sarah, et al.
Publicado: (2016)

Nurse-led safer opioid supply and HIV pre-exposure prophylaxis: a novel pilot project
por: Haines, Marlene, et al.
Publicado: (2022)

Feasibility and Acceptability of an mHealth-Based Approach as an HIV Prevention Strategy Among People Who Use Drugs on Pre-Exposure Prophylaxis
por: Shrestha, Roman, et al.
Publicado: (2020)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Modeling HIV Pre-Exposure Prophylaxis
por: Straubinger, Thomas, et al.
Publicado: (2020)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

Current Perspectives on the Determinants of Acceptability of Pre-Exposure Prophylaxis and Nonoccupational Post-Exposure Prophylaxis among People at Risk for HIV: A Scoping Review
por: Zhou, Lingmi, et al.
Publicado: (2022)

Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with Men
por: Zhou, Feng, et al.
Publicado: (2012)

Application of Bayesian networks to identify factors influencing acceptability of HIV pre-exposure prophylaxis in Guilin, China
por: Zhou, Lingmi, et al.
Publicado: (2022)

Pre-exposure prophylaxis for HIV: effective and underused
por: Hempel, Amanda, et al.
Publicado: (2022)

Pre-exposure prophylaxis for prevention of HIV infection
por: Lee, Joseph Wei En, et al.
Publicado: (2023)

Acceptability and feasibility of the CHARISMA counseling intervention to support women’s use of pre-exposure prophylaxis: results of a pilot study
por: Wilson, Ellen K., et al.
Publicado: (2021)

Acceptability and Feasibility of Pharmacy-Based Delivery of Pre-Exposure Prophylaxis in Kenya: A Qualitative Study of Client and Provider Perspectives
por: Roche, Stephanie D., et al.
Publicado: (2021)

A Guide for Designing Student-Led, Interprofessional Community Education Initiatives About HIV Risk and Pre-Exposure Prophylaxis
por: Bunting, Samuel R., et al.
Publicado: (2019)

987. Improving Patient Access to HIV Post-Exposure Prophylaxis with Pharmacist Involvement
por: Grossman, Katlyn H
Publicado: (2020)

How Acceptable are Antiretrovirals for the Prevention of Sexually Transmitted HIV?: A Review of Research on the Acceptability of Oral Pre-exposure Prophylaxis and Treatment as Prevention
por: Young, Ingrid, et al.
Publicado: (2013)

The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States
por: Adamson, Blythe J. S., et al.
Publicado: (2017)

Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review
por: Xu, Peipei, et al.
Publicado: (2021)

Pharmacist-led teaching as a longitudinal theme for medical school curriculums - a solution for reducing prescribing errors in junior doctors?
por: Lloyd, Naomi
Publicado: (2019)

Correction: Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with Men
por: Zhou, Feng, et al.
Publicado: (2012)

Acceptability and willingness to use HIV pre-exposure prophylaxis among HIV-negative men who have sex with men in Switzerland
por: Gredig, Daniel, et al.
Publicado: (2016)

Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
por: Vanbaelen, Thibaut, et al.
Publicado: (2022)

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis
por: Ahluwalia, Amrit Kaur, et al.
Publicado: (2022)

Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress
por: Mayer, Kenneth H, et al.
Publicado: (2015)

Pre-exposure prophylaxis against HIV: pros and cons
por: Wainberg, Mark
Publicado: (2012)

Top Questions in ID: Pre-exposure Prophylaxis for HIV
por: Krakower, Douglas S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ebc6951ivvrj2b36h472lhn4us